819 TTT
AIKON Health
AIKON Health is a spin‑off from TNO (specifically from TNO’s Holst Centre) that develops wearable biosensors for personalised management of heart‑failure patients. Their flagship product is ...
More informationInvesting in tomorrow's success
819 Capital Partners is a dynamic and forward-thinking investment firm specializing in venture capital, private equity, and corporate finance. Our mission is to drive innovation, growth and value creation for our partners through a diverse portfolio of investments, positively impacting key sectors.
Expertise to realise growth and maximise value
€100M+
Total AUM
Venture, Growth, Control, Buy-and-build
Transaction type
42
Portfolio companies
€500M+
Revenues active investments
1,000+
Portfolio employees
Portfolio
Bekijk alles
819 TTT
819 TTT
UPyTher
UPyTher is a biotech startup from the Netherlands working on novel treatments for peritoneal cancer — a severe cancer type often arising from metastases in the ...
More information
819 Evergreen Fund I
Vivolta
Vivolta is a leading player in the development and implementation of electrospinning processes and equipment for the manufacture of medical devices for (regenerative) medicine and drug delivery.
More information
819 TTT
XS Innovations
XS Innovations is a medical‑device startup (spin‑out of Leiden University Medical Center & Delft University of Technology) that develops an implantable vascular access solution for patients ...
More information
819 Private Equity Fund I
Infoplaza Group
Infoplaza Group (“Infoplaza”) is a multi-media company with more than 100 experts consisting of media meteorologists, editors, IT and designers who provide Weather and Climate news ...
More information
819 Private Equity Fund I
Travelhome
Travelhome is the Dutch market leader for global motorhome travel. The company is specialized in motorhome trips in for example America, Canada, Australia, New Zealand, South ...
More information
819 Evergreen Fund IExit
NovioScan
Novioscan is founded in 2014 and holds its office at the NovioTech Campus in Nijmegen, The Netherlands. The development of wearable ultrasound devices was a result ...
More information
819 Evergreen Fund I
Direct Diagnostics
Direct Diagnostics utilizes advanced technology to provide actionable recommendations and personalized health solutions. The company sells preventive health tests and offers a data-driven eHealth platform for ...
More information
819 Private Equity Fund I
Chalet.nl
Chalet.nl specializes in the organization and rental of chalets and apartments in leading winter sports destinations across France, Austria, Switzerland and Italy. The company has built ...
More information
819 Private Equity Fund I
Viruma
Viruma is a renowned specialist in roofing in the Netherlands. The company is active in roofing, façade systems, and service and maintenance for both new-build and ...
More informationOur news
9 April, 2026
819 Capital Partners invests in Wolk
Deventer, 9 April 2026 - Dutch company Wolk has raised €1.75 million to accelerate the deployment of its smart hip airbag in elderly care. The investment round was led by 819 Capital Partners, through 819 Seed Fund I, and the Innovatiefonds Ouderenzorg of CbusineZ (CZ), with participation from Nivogé, Catalyst Impact Investment Club, and several angel investors. Each year in the Netherlands, approximately 120,000 elderly people end up in the emergency department after a fall....
Continue reading
6 March, 2026
819 Capital Partners acquires key assets of Lead Pharma, enabling continuation of operations
Deventer, 6 March 2026 - 819 Capital Partners has acquired the key assets of Lead Pharma, thereby realizing a continuation based on the company’s patent portfolio and associated research programs. The transaction includes intellectual property rights, research data, and selected development programs. Lead Pharma develops innovative small-molecule medicines for the treatment of cancer and autoimmune diseases. Over the past years, the company built a strong research platform and multiple drug candidates, collaborating with international pharmaceutical companies...
Continue reading